Kari has over 15 years of experience across Phase I unit, operations, feasibility, and site strategy across APAC and England. Kari contributes extensively to Australia pre‑award and business development efforts, offering country‑specific feasibility insights and strategic input during bid defence meetings. Known for aligning study needs with site capabilities, Kari prioritises patient experience and long‑term site relationships, believing that successful trials begin with selecting and supporting the right sites from the outset.
